Outcomes for Human Immunodeficiency Virus-1-Infected Infants in the United Kingdom and Republic of Ireland in the Era of Effective Antiretroviral Therapy

2006 ◽  
Vol 25 (5) ◽  
pp. 420-426 ◽  
Author(s):  
Katja Doerholt ◽  
Trinh Duong ◽  
Pat Tookey ◽  
Karina Butler ◽  
Hermione Lyall ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
United Kingdom ◽  
Antiretroviral Therapy ◽  
Republic Of Ireland ◽  
The United Kingdom ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1

Tenofovir Use in Human Immunodeficiency Virus-1–Infected Children in the United Kingdom and Ireland

2009 ◽  
Vol 28 (3) ◽  
pp. 204-209 ◽  
Author(s):  
Andrew Riordan ◽  
Ali Judd ◽  
Katherine Boyd ◽  
David Cliff ◽  
Katia Doerholt ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
United Kingdom ◽  
The United Kingdom ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1

scholarly journals Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell Responses

2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Sabine Kinloch-de Loes ◽  
Lucy Dorrell ◽  
Hongbing Yang ◽  
Gareth A. D. Hardy ◽  
Sabine Yerly ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Cell ◽  
Antiretroviral Therapy ◽  
Viral Reservoir ◽  
Cell Responses ◽  
Immunodeficiency Virus ◽  
Cellular Immune ◽  
Drug Free ◽  
Human Immunodeficiency Virus 1

Abstract Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enable long-term drug-free virological control in rare individuals. We describe a female who maintained aviremia and a normal CD4+/CD8+ T cell ratio for 10 years after stopping therapy, despite a persistent viral reservoir. Cellular immune responses may have contributed to this outcome.

Sign in / Sign up

Export Citation Format

Share Document